Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:05 pm Unchanged |
2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
Commodore Capital LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:05 pm Purchase |
2024-09-30 | 13G | Nkarta, Inc. NKTX |
Commodore Capital LP | 4,662,073 6.600% |
1,932,073 (+70.77%) |
Filing History |
| 2024-11-14 4:05 pm Purchase |
2024-09-30 | 13G | Cogent Biosciences, Inc. COGT |
Commodore Capital LP | 10,497,990 9.300% |
4,325,904 (+70.09%) |
Filing History |
| 2024-11-14 4:05 pm Purchase |
2024-09-30 | 13G | Spyre Therapeutics, Inc. SYRE |
Commodore Capital LP | 1,988,084 3.900% |
54,000 (+2.79%) |
Filing History |
| 2024-11-14 4:05 pm Sale |
2024-09-30 | 13G | Adicet Bio, Inc. ACET |
Commodore Capital LP | 0 0.000% |
-4,250,000 (Position Closed) |
Filing History |
| 2024-10-25 4:05 pm Purchase |
2024-10-18 | 13G | Bright Minds Biosciences Inc. DRUG |
Commodore Capital LP | 400,000 9.000% |
400,000 (New Position) |
Filing History |
| 2024-10-17 4:05 pm Purchase |
2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT |
Commodore Capital LP | 6,807,507 9.990% |
6,807,507 (New Position) |
Filing History |
| 2024-06-21 4:05 pm Purchase |
2024-06-13 | 13G | Perceptive Capital Solutions Corp Class A Ordinary Shares PCSC |
Commodore Capital LP | 750,000 7.000% |
750,000 (New Position) |
Filing History |
| 2024-04-19 4:05 pm Purchase |
2024-04-11 | 13G | Perspective Therapeutics, Inc. CATX |
Commodore Capital LP | 3,890,667 6.600% |
3,890,667 (New Position) |
Filing History |
| 2024-03-21 4:05 pm Purchase |
2024-03-11 | 13G | Mind Medicine (MindMed) Inc. MNMD |
Commodore Capital LP | 5,833,333 8.300% |
5,833,333 (New Position) |
Filing History |
| 2024-02-14 4:10 pm Purchase |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 5,450,000 12.300% |
448,217 (+8.96%) |
Filing History |
| 2024-02-14 4:05 pm Sale |
2023-12-31 | 13G | Immunic, Inc. IMUX |
Commodore Capital LP | 0 0.000% |
-2,873,563 (Position Closed) |
Filing History |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Commodore Capital LP | 1,000,000 9.900% |
384,186 (+62.39%) |
Filing History |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Commodore Capital LP | 6,172,086 7.100% |
1,246,086 (+25.30%) |
Filing History |
| 2024-02-14 4:05 pm Sale |
2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
Commodore Capital LP | 0 0.000% |
-5,738,500 (Position Closed) |
Filing History |
| 2024-02-14 4:05 pm Unchanged |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Commodore Capital LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Commodore Capital LP | 1,900,000 4.400% |
441,633 (+30.28%) |
Filing History |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | Celcuity Inc. CELC |
Commodore Capital LP | 2,492,886 9.900% |
235,474 (+10.43%) |
Filing History |
| 2024-02-14 4:05 pm Sale |
2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
Commodore Capital LP | 700,000 2.300% |
-185,741 (-20.97%) |
Filing History |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
Commodore Capital LP | 1,934,084 5.400% |
100,000 (+5.45%) |
Filing History |